Special Edition - Early Identification and Delay of Type 1 Diabetes April 2025
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Special Edition - Early Identification and Delay of Type 1 Diabetes April 2025
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
In this special episode on Early Identification and Delay of Type 1 Diabetes, Dr. Neil Skolnik this emerging area with Dr. Jay Shubrook. This special episode is supported by an independent educational grant from Sanofi.
Presented by:
Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health
Jay Shubrook, D.O. - Professor and Director of Diabetes Services, Touro University. Past Chair, The American Diabetes Association Primary Care Advisory Group, Past Chair of the American College of Diabetology.
Selected References and Resources referred to the in the Podcast:
Webinar Registration (Apr 28, 2025 10:00 AM):
Early Detection Saves Lives: Implementing Type 1 Diabetes Screening in Pediatric and Primary Care
References:
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetes Care 2024;47(8):1276–1298
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med 2019;381:603-613
Resources for Auto-antibody Testing:
Type 1 Diabetes TrialNet Centers of Excellence Locations
Type 1 Risk test
Trialnet